Telapristone Acetate
Stage 0 Breast Cancer
Northwestern UniversityPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
17 Active assets in the Stage 0 Breast Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
EXEMESTANE Alliance for Clinical Trials in Oncology | Phase 4 | BBB |
Letrozole Alliance for Clinical Trials in Oncology | Phase 4 | BBB |
TAMOXIFEN Alliance for Clinical Trials in Oncology | Phase 4 | BB |
Arimidex Alliance for Clinical Trials in Oncology | Phase 4 | BB |
Gtx-006 Fred Hutchinson Cancer Center | Phase 4 | BB |
View all 29 →
Same molecule, other indications
Telapristone Acetate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →